Oxford Immunotec Enters into Definitive Agreement to Acquire Imugen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
BTIG Keeps Oxford Immunotec (OXFD) at 'Buy' Amid Imugen Deal; Sees Few Negatives
June 27, 2016 6:40 AM EDTBTIG affirms Oxford Immunotec Global PLC (Nasdaq: OXFD) at Buy with a price target of $17 after the company announced that it entered an agreement to... More
